GlassScriptPhysician profile
Bradley E Hruby
NPI 1194725960
$1,041.45
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $227.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $179.32 | 2019-2020 | |
| Lilly USA, LLC | $177.67 | 2019-2020 | |
| Amgen INC. | $138.98 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $128.88 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $110.53 | 2019 | |
| Sunovion Pharmaceuticals INC. | $99.32 | 2019 | |
| Grifols USA, LLC | $59.62 | 2019 | |
| Novo Nordisk INC | $25.67 | 2019 | |
| Daiichi Sankyo INC. | $22.21 | 2019 | |
| Neos Therapeutics, LP | $18.52 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.45 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.36 | 2019 | |
| Pfizer INC. | $11.83 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Hruby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.